LY-2922470 Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

LY 2922470, has demonstrated potent, efficacious and durable dose dependent reduction in glucose levels along with significant increases in insulin and GLP-1 secretion during preclinical testing. It’s a novel, potent and Selective GPR40 Agonists for the treatment of type 2 Diabetes Mellitus.

LY-2922470 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

LY-2922470 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
TargetMol Chemicals Inc.	+1-781-999-5354 +1-00000000000	marketing@targetmol.com	United States	32080	58
HANGZHOU CLAP TECHNOLOGY CO.,LTD	86-571-88216897,88216896 13588875226	sales@hzclap.com	CHINA	6312	58
Aladdin Scientific	+1-+1(833)-552-7181	sales@aladdinsci.com	United States	52925	58
Jinan elephant international trading co., LTD		13006575422@163.com	China	6355	58
Kaixin Chemical (Hong Kong) Limited	010-88886666-01 13112345678	loyson@tcypharm.com	China	595	55
Dezhou LonWel Pharmaceutical Technology Co., Ltd.	13761310616	39324283@qq.com	China	1991	58
Shanghai Moss Medicine Technology Co., Ltd.	+86-188369842 +86-15618151133	188369842@qq.com	China	1945	58
Hangzhou Synstar pharmaceutical Technology CO.,Ltd	0571-85361029	synstar518@163.com	China	1990	58
ChemeGen(Shanghai) Biotechnology Co.,Ltd.	18818260767	sales@chemegen.com	China	11217	58
Guangzhou Younan Technology Co., Ltd	020-82000279 18988968278	sales@ubiochem.com	China	4297	58

---

• LY2922470
• LY-2922470
• (3S)-3-[4-[[5-[(8-methoxy-3,4-dihydro-2H-quinolin-1-yl)methyl]-2-thienyl]methoxy]phenyl]hex-4-ynoic acid
• (S)-3-(4-((5-((8-METHOXY-3,4-DIHYDROQUINOLIN-1(2H)-YL)METHYL)THIOPHEN-2-YL)METHOXY)PHENYL)HEX-4-YNOIC ACID
• Benzenepropanoic acid, 4-[[5-[(3,4-dihydro-8-methoxy-1(2H)-quinolinyl)methyl]-2-thienyl]methoxy]-β-1-propyn-1-yl-, (βS)-
• LY 2922470,LY-2922470,LY2922470,Free Fatty Acid Receptor,inhibit,Inhibitor,FFAR
• 1423018-12-5